beta-ADRENOCEPTORS IN THE MEDIAL AMYGDALOID NUCLEUS MODULATE THE TACHYCARDIAC RESPONSE TO RESTRAINT STRESS IN RATS


Autoria(s): Fortaleza, E. A. T.; Scopinho, A. A.; Correa, F. M. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

30/10/2013

30/10/2013

02/08/2013

Resumo

In the present study, we investigated the involvement of beta-adrenoceptors in the medial amygdaloid nucleus (MeA) in cardiovascular responses evoked in rats submitted to an acute restraint stress. We first pretreated Wistar rats with the nonselective beta-adrenoceptor antagonist propranolol microinjected bilaterally into the MeA (10, 15, and 20 nmol/100 nL) 10 min before exposure to acute restraint. The pretreatment with propranolol did not affect the blood pressure (BP) increase evoked by restraint. However, it increased the tachycardiac response caused by acute restraint when animals were pretreated with a dose of 15 nmol, without a significant effect on the BP response. This result indicates that beta-adrenoceptors in the MeA have an inhibitory influence on restraint-evoked heart rate (HR) changes. Pretreatment with the selective beta(2)-adrenoceptor antagonist ICI 118,551 (10, 15, and 20 nmol/100 nL) significantly increased the restraint-evoked tachycardiac response after doses of 15 and 20 nmol, an effect that was similar to that observed after the pretreatment with propranolol at a dose of 15 nmol, without a significant effect on the BP response. Pretreatment of the MeA with the selective beta(1)-adrenoceptor antagonist CGP 20712 (10, 15, and 20 nmol/100 nL) caused an opposite effect on the HR response, and a significant decrease in the restraint-evoked tachycardia was observed only after the dose of 20 nmol, without a significant effect on the BP response. Because propranolol is an equipotent antagonist of both beta(1) and beta(2)-adrenoceptors, and opposite effects were observed after the treatment with the higher doses of the selective antagonists ICI 118,551 and CGP 20712, the narrow window in the dose-response to propranolol could be explained by a functional antagonism resulting from the simultaneous inhibition of beta(1) and beta(2)-adrenoceptors by the treatment with propranolol. The present results suggest that beta(2)-adrenoceptors have an inhibitory influence on the restraint-evoked tachycardiac response, whereas beta(1)-adrenoceptors have a facilitatory influence on the restraint-evoked tachycardiac response. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

CNPq [140118/2009-8, 501269/2005-3]

CNPq

CAPES [PNPD0176087]

CAPES

Identificador

NEUROSCIENCE, OXFORD, v. 227, n. 4, supl. 4, Part 1-2, pp. 170-179, DEC 27, 2012

0306-4522

http://www.producao.usp.br/handle/BDPI/36958

10.1016/j.neuroscience.2012.09.048

http://dx.doi.org/10.1016/j.neuroscience.2012.09.048

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

OXFORD

Relação

NEUROSCIENCE

Direitos

closedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #MEDIAL AMYGDALOID NUCLEUS #BETA-ADRENOCEPTORS #CARDIOVASCULAR SYSTEM #RESTRAINT STRESS #SPONTANEOUSLY HYPERTENSIVE-RATS #VENTRAL NORADRENERGIC BUNDLE #ACUTE IMMOBILIZATION STRESS #CARDIOVASCULAR-RESPONSES #NEUROENDOCRINE RESPONSES #STRIA TERMINALIS #BED NUCLEUS #UNANESTHETIZED RATS #MESSENGER-RNA #PSYCHOLOGICAL STRESSORS #NEUROSCIENCES
Tipo

article

original article

publishedVersion